You are the Vice-President for International Development of a small U.S. pharma

You are the Vice-President for International Development of a small U.S. pharmaceutical company (located in Emeryville California) which
specializes in the development of new medical vaccines using unique biotechnological know-how. Until now the company has only achieved small successes in
limited markets. Recently however the company developed a vaccine to protect humans against the MERS virus. According to the World Health Organization this
virus has already been identified in Europe and the Arabian peninsula two areas where the need for a vaccine is urgent and immediate. The virus is not yet a
major problem in South America North America or Asia. The company has limited manufacturing capability; if the MERS virus reaches epidemic proportions in
Europe and the Arabian peninsula it will not have the capability to supply large enough quantities to meet demand. The company wants to determine the best way
it should supply the markets where the virus is currently a problem and which entry mode or modes it should use. The possibilities are:
a) Manufacture the product at home and export to the European markets and the Arabian peninsula b) License the formula out to a company
already established in each of these two regions c) Enter into a strategic alliance with a large pharmaceutical company and establish a 50/50 joint venture
company which would manufacture and market the product in these two regions) d) Establish wholly owned subsidiaries in the afflicted areas e) another
alternative you might identify. As the Vice-President you must make some strategic decisions:

a) Which entry mode or modes (entry strategy/strategies) would you follow in Europe and the Arabian peninsula?

b) Why would you choose this strategy or strategies instead of the other alternatives? Explain what the advantages are of the entry more or
modes you are recommending and what the disadvantages of the other modes are.

c) What entry mode would you use in those regions where MERS is not yet a major threat and demand is not as urgent (South America North
America Asia)? Why would you recommend this entry mode or modes?